Citius Pharmaceuticals, Inc.

CTXR · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 23 employees
309
SEC Filings
$0.5731
Close 2026-09-14
23
Employees

Business Summary

Citius Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Cranford, New Jersey, focused on developing and commercializing critical care products in oncology and anti-infectives. Its majority-owned subsidiary Citius Oncology launched LYMPHIR (denileukin diftitox-cdxl) in December 2025 for persistent or recurrent cutaneous T-cell lymphoma. Pipeline products include Mino-Lok (catheter infection treatment), Halo-Lido (hemorrhoid topical formulation), and NoveCite (mesenchymal stem cell therapy for ARDS).

Latest Stock Quote

CTXR 2026-09-14 $0.5731 O:$0.58 H:$0.59 L:$0.5701 Vol:0.2M VWAP:$0.5842
origin leaf: null

Next Earnings

expected 2026-11-13

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-12-232025-09-300001213900-25-125333EDGAR76K words
2024-12-272024-09-300001213900-24-113149EDGAR68K words
2023-12-292023-09-300001213900-23-099889EDGAR62K words
2022-12-222022-09-300001213900-22-082217EDGAR54K words
2021-12-152021-09-300001213900-21-065464EDGAR—
2020-12-162020-09-300001213900-20-043004EDGAR—
2019-12-162019-09-300001213900-19-026259EDGAR—
2018-12-112018-09-300001213900-18-017214EDGAR—
2017-12-132017-09-300001213900-17-013191EDGAR—
2016-12-232016-09-300001477932-16-014315EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-142026-06-300001213900-26-090185EDGAR28K words
2026-02-132025-12-310001213900-26-015878EDGAR21K words
2025-08-122025-06-300001213900-25-074997EDGAR22K words
2025-05-142025-03-310001213900-25-043360EDGAR20K words
2025-02-142024-12-310001213900-25-014321EDGAR15K words
2024-08-122024-06-300001213900-24-067732EDGAR18K words
2024-05-142024-03-310001213900-24-042920EDGAR16K words
2024-02-142023-12-310001213900-24-014096EDGAR14K words
2023-08-142023-06-300001213900-23-067024EDGAR15K words
2023-05-122023-03-310001213900-23-039031EDGAR14K words
2023-02-102022-12-310001213900-23-010315EDGAR13K words
2022-08-112022-06-300001213900-22-046897EDGAR16K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-210001213900-26-092604EDGAR1K words
2026-08-140001213900-26-090181EDGAR4K words
2026-08-050001213900-26-085432EDGAR2K words
2026-04-060001213900-26-040474EDGAR1K words
2026-03-310001213900-26-037524EDGAR3K words
2026-03-100001213900-26-025459EDGAR3K words
2026-03-040001213900-26-023439EDGAR3K words
2026-02-130001213900-26-015895EDGAR3K words
2025-12-230001213900-25-125413EDGAR3K words
2025-12-010001213900-25-116760EDGAR3K words

309 total filings indexed. 277 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

oncology anti-infectives-in-adjunct-cancer-care critical-care cutaneous-t-cell-lymphoma catheter-related-bloodstream-infections acute-respiratory-distress-syndrome

Company Identity

CIK0001506251
TickerCTXR
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedNV
HeadquartersCranford, New Jersey
Websitehttps://www.citiuspharma.com
Listed2011-10-18

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: efb13a0c85642e52f59b76c125c6903f24169814debb56f1ca2edfdb2964e884
parent: 6fcda733ab50fe14f1dcc61ff863d4d9fb7ab26b0ee7b3a047af2092250343dc
content hash: f21e3db5d6fe3dea1312d906683819123c4fdbb3ca336a121fbf202bc2e77db3
signed: 2026-09-30T12:00:55.569Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up CTXR using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on CTXR, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/CTXR (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.